Concepedia

Publication | Closed Access

Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis

36

Citations

47

References

2018

Year

Abstract

Our data implicate NCT as a potential therapeutic target in myelofibrosis and provide a rationale for clinical evaluation in ruxolitinib-exposed patients with myelofibrosis.

References

YearCitations

Page 1